Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
* TCM Charts * $3.24
* SHZ Charts * $1.15
* CAEI Charts * $5.29
... note the ($5.45) gap from May 9th is filled finally.... time to uptrend?
.... or double bottom @ $4.75 on the 2 year daily?
Anybody know what company this is?:
Their 2008 Q2 revenue was more than three times that of 2007's Q2 revenue.
In the last couple of months, the company has signed contracts worth more than Q2's (2008) total revenue.
Those recent contracts are only about 5% of the orders they already have, and are waiting to fill.
The kind of business they're in is close to being mandated by the government.
Their product saves companies money, and helps save the environment too.
It requires four times as much energy to generate one unit of GNP (gross national product) in China than it does in the U.S.
The electricity distribution system in China is struggling to meet the demand. Temporary electric power shortages are becoming common, which is a particular problem for a country still growing its industrial machine.
China meets 2/3 of its energy needs by burning coal, which is one of the dirtiest fossil fuels. Acid rain caused by SO2 pollution has affected 1/3 of China's farmland. Some soil can't be farmed any longer.
China's government has vowed to shut down inefficient factories in high-pollution industries, which are primarily electricity, coal, and steel.
Clearly those are problems that can't be left alone. Wouldn't be interesting if a company could tackle those problems head on with a real solution? Hmmmm.
The SmallCapNetwork is highlighting/profiling/pumping the above company and will release a profile on Friday after the market close. It has piqued my interest. I've been 'Googling' but haven'thad any luck. Any thoughts appreciated. SmallCapNetwork can be found at the following link:
www.smallcapnetwork.com
GLTA,
Murocman
Oh yes Randy .....very close to CNEH.... well not too close to those communists BUT the bank account made buddies w/ 'em.... the chart has been posted here and the Positive Possibilities Board .... USUALLY BEFORE every run.... you know how we do it......
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=27423165
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=28874022
Great board and system too BTW....
...and remember my good man.... don't get too close too 'em... they're still communist....(and still a bb)
fib says "fight at 3.64 and a battle at 4.05 .... Thanks again for the message Friend and GL 2 U ....
JT
Support/Resistance
resist. 5.67 2
resist. 4.95 3
resist. 4.63 6
resist. 4.45 3
resist. 4.31 6
resist. 4.05 12
resist. 3.64 6
resist. 3.25 3
resist. 3.08 2
supp 2.91 3
supp 2.06 2
"Where Liberty Dwells; There Is My Country" Dr. Benjamin Franklin
Appreciate the message 2morrowsGains..... Thanks ....we'll be sure to keep it on radar again .... I remember playing this one a couple times.....
spinning top and decent volume to finish the week ... could be time for reversal.....
Thanks again and have a great weekend....
Blue Skies, Green $creens,
JT
Fib says...." there is a tough fight at the $2.04 range...."
Support/Resistance
Type Value Conf.
resist. 3.00 2
resist. 2.68 2
resist. 2.52 5
resist. 2.25 3
resist. 2.19 5
resist. 2.04 20
supp 1.81 6
supp 1.70 2
Hey JT...I just found this board. Did I miss it or are you guys not tracking CNEH Chinese North East Petroleum?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=31847469
Here's my rating of it from AS IRON SHARPENS IRON:
CNEH Evaluation by AS IRON SHARPENS IRON Criteria
COMPANY CNEH.BB
1. SHARE STRUCTURE ----------------------------10 (a)
2. TRADING EXCHANGE-----------------------------8
3. INSIDER ACTIVITY/OWNERSHIP---------------9
4. DEBT STRUCTURE/DILUTION/CASH FLOW--8 (b)
5. REVENUE GENERATION-------------------------10
6. PROMOTION---------------------------------------9
7. GROWTH POTENTIAL-----------------------------10
8. MANAGEMENT SKILL/HISTORY-----------------8
9. MACRO-ECONOMIC SENSE---------------------9
10. TRADING VOLUME/RANGE---------------------9 (c)
Total -----------------------------------------------------90
I believe this is about the highest rank I have given to any company.
Notes:
(a) Public fload is puny. 18.7 Million shares were issued to affect the reverse merger.
(b) It appears the S-1 Filing was planned from the inception of the $15 Million debentures. I don't believe the debentures are convertable to shares, but default will result in tranfer of assets from one of the oil fields purchased (using the debentures)..
(c) The stock is presently trading at low end of recent range I believe mostly out of concern for the S-1. It may go a little lower, but my guess is the shares will be gobbled up.
Said differently, if I had some liquidity I would be a buyer.
HOLI...HLS Systems is another Chinese company that looks to have enormous long term growth potential. (Uplisted to the NASDAQ a few weeks ago). They are an Alt Energy company that develops and sells automation and control systems for the industrial, rail, subway, coal power and nuclear power sectors. They also recently announced that they are entering the Wind Energy sector (control systems for wind turbines) and hope to capture a big part of that market as well...
http://en.hollysys.com/en/showtzzgx.aspx?column_id=1425
Here is an interview with HOLI's CEO from 8/9/08...
http://cosmos.bcst.yahoo.com/up/player/popup/?rn=3906861&cl=9196008&ch=4226720&src=news
Also, this was taken from their most recent earnings PR...
- "HLS’ gross margins are expected to increase and average over 30% for the remainder of 2008 and 2009." (Compared to 22.7% for the three months ended March 31, 2008).
Industrial Automation
Our core industrial automation business continues to benefit from a growing focus by Chinese manufacturers on productivity, quality and safety, and wage increases for Chinese workers are forcing factories to automate to stay competitive. We continue to focus our efforts on high growth opportunities in this business segment, and are pursuing a strategic alliance with a major PRC energy group to offer exclusive automation control products and services for their power plants. In addition, we are also focused on providing control systems to the rapidly expanding alternative energy market, including wind and biomass, and are pursuing alliance with a leading wind energy company in China to provide automation controls for their wind turbines exclusively.
Nuclear Power
We also remain very excited about our near term prospects in the nuclear automation and control systems segment of our business. The nuclear power market opportunity in China is huge and growing, as the PRC government recently announced plans to increase the nuclear build-out from 40 1GW reactors to 70 1GW reactors by 2020. As a result of our joint venture with Guangdong Nuclear Power Group (“GNPG”), the leading nuclear power plant operator in PRC, we believe we are uniquely positioned to be the dominant instrumentation and control system provider within the Chinese nuclear power industry.
In July 2007, we announced that our joint venture with GNPG signed contracts totaling $97 million to develop control systems for 6 1GW reactors and we expect to enter additional contracts in the future.
Rail/Subway
Another exciting segment of our business involves control systems for rail and subway networks. This continues to represent a large and growing market driven by the continued build-out of transportation infrastructure and the mandated replacement of old technology upgrades for safety purposes. Within this market segment, we remain particularly excited about the opportunities with high speed rail networks and are positioning HLS to be the premier provider of the control systems for these networks. In January 2008, we announced the signing of a 200 kilometer per hour high speed rail control system contract worth $19.9 million. Based on our performance on the previous contracts and the successful testing and implementation of control systems for trains at this speed and faster, we are well-positioned to win additional contracts for high speed rail systems ranging from 200 to 300 kilometers per hour.
Automation & Drive
In addition to the continued growth of our automation control system business, we also look forward to entering the surging automation and drive market and feel it will be a great complement to our core automation control business. The automation and drive business combines motor and drive technologies with our control systems to offer customers a totally integrated solution.”
http://en.hollysys.com/en/showtzzgx.aspx?column_id=1422
The information posted by 2morrowsGains is opinion only and should not to be taken as investment advice.
CHME. (JT_Options)...CHME released a white paper a few weeks ago on their proprietary rADTZ enzyme product...
http://www.chinamedicinecorp.com/PDFview/ADTZ%20White%20Paper.pdf
Pretty big potential here IMO. They mentioned in their earnings PR that they hope to capture 20% of the animal feed market over the next 3 years. This was taken from the white paper...
"Thus, the size of the potential domestic feed market for rADTZ is around RMB 2.7 billion ($392.3 million) per year. In the past five years, the market for industrial enzymes in feed has experienced rapid growth of 11% a year, and is projected to reach RMB 5.5 billion ($800 million) by 2010."
Using the $800M number, here's what I come up with...
$800M x 20% = $160M in rADTZ sales per year by 2011 just for the China market with 90%+ gross margins. The 90%+ GM was mentioned in the cc.
(rADTZ will more than likely be introduced in other countries by then also).
Also from the cc...
- CHME is looking at approx $30M (USD) in costs for a manufacturing facility that will support expansion of the company's rADTZ as well as the manufacturing of pharmaceuticals. Still evaluating the situation along w/ the financing.
- They already engaged a distributor here in the US to do trial sales of a new weight loss product.
- Looking at introducing a new product in Pakistan.
- Would like to list on the NASDAQ but needs a $4 share price to list on that exchange.
RE : Share structure...
Including all warrants and options there are approx 19.6M shares fully diluted outstanding. (Strike price on warrants is $2.43 on approx 2.9M shares and $1.70 on 100k shares). At the 19.6M share count, CHME still earned $0.125 a share last quarter!! The share price is $2.17. The stock looks undervalued.
The information posted by 2morrowsGains is opinion only and should not to be taken as investment advice.
Thanks for the charts
* CHME Charts * $2.27
Thanks for the message 2morrowGains....GL 2 U....
* CNOA Charts * ¢.27
trending lower, oversold, ....may pinch..... GL 2 U
Thanks for the message Friend....
"Where Liberty Dwells; There Is My Country" Dr. Benjamin Franklin
CHME...Nice earnings report out this morning. EPS = $0.16 with a share price of $2. And "based on our strong second quarter profitability, we expect to EXCEED our net income guidance of 20%-22% for 2008"...
China Medicine Announces Strong Second Quarter 2008 Results
Wednesday August 13, 8:00 am ET
Revenues increased 40.8% to $11.6 million
Net Income increased 118.8% to $2.5 million
GUANGZHOU, China, Aug. 13 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME - News; "China Medicine" or "the Company"), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and dietary-supplements, medical devices, and medical formulations in the People's Republic of China ("PRC"), today reported strong financial results for the second quarter ended June 30, 2008.
Second Quarter 2008 Highlights:
-- Revenues increased 40.8% to $11.6 million
-- Gross profit increased 72.8% to $4.2 million
-- Operating income increased 107% to $3.0 million
-- Net income increased 118.8% to $2.5 million, or $0.16 per diluted share
"We are pleased to report strong revenue growth driven by an increase in sales of pharmaceutical products through exclusive nationwide and regional distribution rights, competitive pricing, timely delivery of products and excellent after-sales customer service," commented Mr. Senshan Yang, Chairman and CEO of China Medicine.
Revenues for the second quarter of 2008 grew 40.8% to $11.6 million from $8.3 million in the second quarter of 2007. The increase was attributable to an overall increase in sales from the Company's pharmaceutical product portfolio. Sales of pharmaceutical products obtained though the Guangdong Sunshine Medicine Public Internet Bidding System contributed to 35% of total revenues. Sales of pharmaceutical products with national distribution rights made up 35.7% of total revenues, and sales of products with manufacturing license accounted for 5.6% of total revenues. Sales of pharmaceutical products with regional-level distribution rights made up 23.7% of total revenues.
Product sales totaled $11.1 million and accounted for 95.1% of total net revenues. Sales of Western-style prescription and over-the-counter products accounted for 66.1% of total revenues for the second quarter. Sales of TCM prescription and over-the-counter products accounted for 26.9% of total revenues. Medical formula sales, which totaled $0.57 million, accounted for 4.9% of total revenues, representing an increase of 14% over the second quarter of 2007.
Gross profit in the second quarter of 2008 was $4.2 million, an increase of 72.8% over the second quarter of 2007. Gross margin increased significantly in the second quarter to 35.7% versus 29.1% for the same period in 2007, and 33.7% in the first quarter or 2008. The increase in gross margin was attributable to the Company's strategy of restructuring its product portfolio mix, which includes higher-margin prescription pharmaceutical products and less over-the-counter generic pharmaceutical products.
Operating expenses in the second quarter of 2008 were $1.2 million, up 21.5% from $0.96 million in the second quarter of 2007. The increase was due to higher selling, general and administrative expenses, but was less than the increase in revenues for the quarter. Operating expenses represented 10.0% of total revenues in the second quarter of 2008, down from 11.6% in the second quarter of 2007.
Operating income was $3.0 million in the second quarter of 2008, up 107% from $1.4 million in second quarter of 2007. Operating margin for the second quarter of 2008 was 25.7% compared to 17.5% for the second quarter of 2007.
Net income for the second quarter of 2008 was $2.5 million or $0.16 per diluted share, up 118.8% from $1.1 million, or $0.08 per diluted share in the second quarter of 2007. Earnings per share reflect an increase of 1.4 million diluted average shares compared to the second quarter of 2007, primarily due to the exercise of warrants and options.
Six Month Results
For the first half of 2008, revenues increased to $18.7 million, up 40% from $13.4 million in first half of 2007. Gross profit increased 58.1% to $6.5 million in the first six months of 2008, versus $4.1 million in the first six month of 2007. Gross margin was 34.6% in the first half of 2008 compared to 30.6% during the first half of 2007. Operating income in the first half of 2008 grew 84.3% to $4.4 million compared to $2.4 million in the first half 2007. Net income for the first six months of 2008 was $3.6 million or $0.23 per diluted share, up 92.6% from $1.9 million, or $0.15 per diluted share in the first half of 2007.
Financial Condition
As of June 30, 2008, China Medicine had approximately $34.2 million in working capital, an increase of 20% from $28.5 million as of December 31, 2007. Also as of June 30, 2008, China Medicine had $2.8 million in cash and cash equivalents, a decrease of 51.7% from $5.8 million as of December 31, 2007. For the six months ended June 30, 2008, cash used in operating activities was $2.99 million, compared to $3.1 million for the six months ended 2007. Cash used in operating activities is largely related to the Company's account receivable and advance payments to suppliers. Stockholders' equity as of June 30, 2008 was $37.0 million, an increase of 20% over the $30.9 million recorded as of December 31, 2007.
Business Outlook
China Medicine is actively expanding its product portfolio to include higher margin products in order to increase profitability. In the first half of 2008, the Company maintained distribution rights, through the Guangdong Sunshine Medicine Public Internet Bidding System, to sell all pharmaceutical products included in its current catalogue. This enables the Company to increase gross margin since it reduces expenses tied to introducing new products into the market.
During the quarter, China Medicine also achieved a major milestone in obtaining a patent for recombinant aflatoxin-detoxifizyme (rADTZ) in Australia that is valid through January 13, 2025. This is in addition to a patent granted in early 2004 from State Intellectual Property Office of China. The Company has applied for rADTZ patents in 13 different jurisdictions in 2007 (including Australia, Canada, the European Union, Indonesia, Israel, Japan, South Korea, Mexico, Russia, South Africa, the U.S., Hong Kong and India). China Medicine is currently testing rADTZ on animal feed and is scheduled to begin working with the Chinese Department of Agriculture on a large scale experiment in order to meet national standards and apply for production permits. Due to the 2008 Beijing Olympics Games, the application for a production permit will be delayed since the Chinese government mandated that all toxic tests and experiments be temporarily halted before and during the Olympics. Therefore, further testing on rADTZ will be suspended for approximately three months.
To date, the Company has been approached by potential customers for rADTZ, including a large scale chicken farm in Guangzhou Province; a leading international provider of food, agriculture and risk management products and services; and an international manufacturer of enzymes for the detergent, textile, and food and feed industries. "The entrance of rADTZ in the animal feed industry is relatively easy since we will only need approval from the Department of Agriculture in China, which is in contrast to entering the food industry, where the process might take years," said Mr. Yang. "Therefore, our target market is China's entire feed industry, which is approximately RMB 274.2 billion ($39.8 billion, 1 RMB = $0.145). In the next three years, we hope rADTZ will capture 20% of the animal feed market," said Mr. Yang.
"Based on our outstanding first half 2008 performance, we feel confident that we will meet our guidance of 25%-35% revenue growth and 30%-35% gross margins for fiscal 2008. In addition, based on our strong second quarter profitability, we expect to exceed our net income guidance of 20%-22% for 2008," concluded Mr. Yang.
Conference Call
China Medicine will hold its second quarter conference call for all interested persons at 10:00 a.m. Eastern Time on August 13, 2008 to discuss its results. To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 888.482.0024. International callers should dial 617.801.9702. When prompted by the operator, mention conference passcode 38093968. If you are unable to participate in the call at its scheduled time, a replay will be available for seven days starting on Wednesday, August 13 at 12:00 p.m. Eastern Time. To access the replay, dial 888-286-8010 (international callers dial 617-801-6888), and enter the passcode 73037488.
About China Medicine Corporation
China Medicine Corporation is a leading pharmaceutical company that discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over-the-counter drugs, traditional Chinese medicine products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces and to more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website a thttp://www.chinamedicinecorp.com .
Cautionary Statement
This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risk factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward- looking statement to reflect events or circumstances after the date of this release.
--FINANCIAL TABLES FOLLOW--
CHINA MEDICINE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME
(Unaudited)
Three months ended Six months ended
June, 30 June, 30
2008 2007 2008 2007
REVENUES
Product sales $11,067,074 $7,764,535 $17,918,458 $12,647,744
Medical formula sales 570,465 499,433 780,120 709,219
Total revenues 11,637,539 8,263,968 18,698,578 13,356,963
COST OF GOOD SOLD 7,481,170 5,859,008 12,230,189 9,264,425
GROSS PROFIT 4,156,369 2,404,960 6,468,389 4,092,538
OPERATING EXPENSES
Research and
development 107,824 543 196,216 100,655
Selling, general and
administrative 1,060,082 960,924 1,872,590 1,604,770
Total operating
expenses 1,167,906 961,467 2,068,806 1,705,425
INCOME FROM OPERATIONS 2,988,463 1,443,493 4,399,583 2,387,113
OTHER INCOME (EXPENSE),
NET 32,104 (7,118) 38,087 (10,090)
INCOME BEFORE INCOME
TAXES AND MINORITY
INTEREST 3,020,567 1,436,375 4,437,670 2,377,023
PROVISION FOR INCOME
TAXES 572,176 338,326 840,943 538,285
INCOME BEFORE MINORITY
INTEREST 2,448,391 1,098,049 3,596,727 1,838,738
MINORITY INTEREST 17,833 29,085 45,310 52,117
NET INCOME 2,466,224 1,127,134 3,642,037 1,890,855
OTHER COMPREHENSIVE
INCOME
Foreign currency
translation
adjustment 744,658 559,325 2,071,824 559,325
COMPREHENSIVE INCOME $3,210,882 $1,686,459 $5,713,861 $2,450,180
EARNINGS PER SHARE
Basic $0.16 $0.09 $0.24 $0.18
Diluted 0.16 0.08 0.23 0.15
WEIGHTED AVERAGE SHARES
OUTSTANDING
Basic 15,206,124 12,160,111 15,118,595 10,692,414
Diluted 15,634,713 14,232,457 15,547,183 12,764,759
CHINA MEDICINE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2008 AND DECEMBER 31, 2007
A S S E T S
2008 2007
Unaudited
CURRENT ASSETS
Cash $2,771,459 $5,767,774
Accounts receivable, trade, net of
allowance for doubtful accounts
of $59,212 and $55,640 as of June
30, 2008 and December 31, 2007,
respectively 15,176,874 13,626,347
Notes receivables 1,718,702 --
Inventories 5,029,693 3,948,460
Advances to suppliers 9,937,629 5,983,277
Other current assets 86,003 81,221
Total current assets 34,720,360 29,407,079
EQUIPMENT, net 1,296,716 1,388,919
OTHER ASSETS
Deferred expenses 541,328 678,237
Deposit for patent 622,993 --
Intangible assets, net 1,240,804 1,166,003
Total other assets 2,405,125 1,844,240
Total assets $38,422,201 $32,640,238
L I A B I L I T I E S A N D
S H A R E H O L D E R S' E Q U I T Y
CURRENT LIABILITIES
Accounts payable, trade $104,401 $76,907
Other payables and accrued
liabilities 19,686 70,343
Customer deposits 221,401 203,281
Taxes payable 115,782 468,184
Liquidated damages payable 44,003 44,003
Total liabilities 505,273 862,718
MINORITY INTEREST 904,070 893,337
SHAREHOLDERS' EQUITY
Preferred stock, $0.0001 par value;
10,000,000 shares authorized,
- and 111,649 shares issued and
outstanding at June 30, 2008 and
December 31, 2007, respectively -- 11
Common stock, $0.0001 par value;
100,000,000 shares authorized,
15,226,742 and 14,821,641 shares
issued and outstanding at June 30,
2008 and December 31, 2007,
respectively 1,522 1,482
Paid-in capital 12,974,863 12,560,078
Statutory reserves 2,191,230 2,191,230
Retained earnings 17,650,624 14,008,587
Accumulated other comprehensive
income 4,194,619 2,122,795
Total shareholders' equity 37,012,858 30,884,183
Total liabilities and
shareholders' equity $38,422,201 $32,640,238
CHINA MEDICINE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2008 AND 2007
(Unaudited)
2008 2007
CASH FLOWS FROM OPERATING
ACTIVITIES:
Net income $3,642,037 $1,890,855
Adjustments to reconcile net income
to cash used in operating activities:
Minority interest (45,310) (52,117)
Depreciation and amortization 193,572 130,330
Bad debt expense -- 876
Stock issued for services -- 134,550
Amortization of stock option and
warrant compensation 52,314 50,258
Amortization of deferred expenses 175,421 --
Loss on currency exchange -- 19,620
Change in operating assets
Accounts receivable, trade (657,089) 521,256
Notes receivables (1,670,875) --
Inventories (804,759) (2,500,265)
Advances to suppliers (3,473,818) (3,356,149)
Other current assets 420 (15,919)
Change in operating liabilities
Accounts payable, trade 21,928 30,328
Other payables and accrued
liabilities (52,364) (67,809)
Other payables-related parties -- 30,772
Customer deposits 4,931 (157,245)
Taxes payable (371,810) 245,048
Liquidated damages payable -- 1,133
Net cash used in operating
activities (2,985,402) (3,094,478)
CASH FLOWS FROM INVESTING
ACTIVITIES:
Deposit for patent (605,657) --
Purchase of equipment (17,226) (214,162)
Purchase of intangible asset -- (132,011)
Net cash used in investing
activities (622,883) (346,173)
CASH FLOWS FROM FINANCING
ACTIVITIES:
Proceeds from exercise of warrants
and options 362,500 5,717,789
Net cash provided by financing
activities 362,500 5,717,789
EFFECT OF EXCHANGE RATE ON CASH 249,470 54,060
(DECREASE) INCREASE IN CASH (2,996,315) 2,331,198
CASH, beginning of period 5,767,774 371,480
CASH, end of period $2,771,459 $2,702,678
Thoughts on CNOA?
This looks like it is way undervalued heading into earnings the end of the week. I took a postion Friday.
Anybody else have any thoughts?
Murocman
JST daily charts
"Where Liberty Dwells; There Is My Country" Dr. Benjamin Franklin
* SHZ daily charts * $2.10
"Where Liberty Dwells; There Is My Country" Dr. Benjamin Franklin
CYD daily charts
"Where Liberty Dwells; There Is My Country" Dr. Benjamin Franklin
* CHNG daily Charts * $5.05
Good day and good luck May Lee....
JT
"Where Liberty Dwells; There Is My Country" Dr. Benjamin Franklin
I've liked CHNG for some time...
Here is an interesting article.
http://www.cbsnews.com/stories/2008/07/17/cbsnews_investigates/main4267154.shtml
*
*
*
The POWER of the Internet. Like the Six Gun in the Old West called an Equalizer.
Do your own DD, This post is my OPINION. ** TRUST, BUT VERIFY.**
wow Friend.... lots and lots of bottom in on these communist / American plays.......
Be sure to cover Ibox for those money makers that are reversing... (emerging markets wayyyyy oversold imo... many turning .... lots of stocks to choose from......
CPSL, CHNG, XSNX, SHZ, XFML, FEED, CAEI, HMIN are a few that come to mind ......bread winners that is....
Talk with you soon Sir and Good Luck,
Blue Skies, Green $creens,
JT
DRGG at .07/.075 gave guidance of .04-.05/share income in 2009
They made .02/share in last 9 months, and are projecting .04-.05/shar in fiscal 2009 (their fiscal year started July 1).
I'm a buyer of it here.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=6038880-7778-11466&type=sect...
Dear Fellow Shareholder:
Dragon International Group has experienced substantial growth for the first nine months of fiscal 2008 as we transitioned our business for the future. We decided to exit the low margin cigarette packaging business as we focused our efforts in the food and pharmaceutical packaging business where margins and growth prospects are far more robust. In October of 2007 we acquired a 100% equity interest in Wellton International Fiber Corp. (“Wellton”), a company engaged in the distribution of paper products and pulp. This acquisition, coupled with our focus on our higher margin packaging operations has been the key driver to the significant improvement in our operating results for the first nine months of fiscal 2008.
Our revenue in the first nine months of fiscal 2008 reached $33.3 million with net income rising to $2.2 million or $0.02 per share, as compared to revenue of $13.3 million and a net loss of $350,000 in the first nine months of fiscal 2007. We are confident that the company is well positioned for continued growth for the remainder of this fiscal year which ends on June 30, 2008 and into fiscal 2009. For fiscal 2009, management currently estimates that revenue will exceed $50 million with earnings reaching $5 million or in the range of $0.04 to $0.05 per share.
We believe that as a result of the decisions made in fiscal 2008, we are poised to take advantage of the substantial growth opportunities in specialty packaging. We anticipate the Chinese government will continue its initiative to increase quality standards in pharmaceutical packaging which will have a positive impact on the overall growth of this industry as well as the growth of our operations. We intend to broaden our product lines and increase our marketing efforts in order to substantially accelerate the growth of our pharmaceutical packaging operations in the coming years. We believe that the pharmaceutical packaging industry in China will remain a high growth sector for many years to come as evidenced by the fact that its market size was roughly US$2 billion in 2007 as compared to US$30 billion in the United States. We are confident that we can grow this business significantly while maintaining healthy profit margins as we strive to increase our shareholder value. Management further believes its pulp and paper operations at Wellton will continue to grow organically and maintain a double digit growth rate for the foreseeable future.
In closing, as Chairman of Dragon International Group, I feel it is important for you to know that we are determined to maximize the value of our company for its shareholders. We head into fiscal 2009 in a strong financial position with high expectations for the future. We will continue to look for opportunistic acquisitions that will complement our current operations. We intend to focus on horizontal consolidation opportunities as we work diligently to have our company emerge as a market leader in the packaging industry. We are confident that we have the right initiatives, the correct business model and the right leadership to capitalize on the significant market opportunities we have in China. We would like to thank you for your support and look forward to maximizing the value of DRGG for you, our shareholders, in the years to come.
Sincerely,
David Wu
Chairman of the Board
Investor Presentation from last week:
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=6038880-5844-7631&type=sect&dcn=0001266454-08-000392
Website:
http://www.drgg.us/
I like them both and made a lot of money last year with CFSG.
I like SINE (formally SNEN) better than CHNG though. They'll be going to Naz soon it looks like (see news this week).
Have no position in either here.
CHSH has been holding up OK in this market- considering it's so thinly trded and a true penny stock. A lot of potential there IMO.
CHNG and CFSG ready? ..... looking attractive .....
"Where Liberty Dwells; There Is My Country" Dr. Benjamin Franklin
News on China Shoe today- now with 11 retail stores open, and 6 more to open soon.
http://biz.yahoo.com/prnews/080630/cnm028.html?.v=28
Couldn't agree more Brick on CJGH! Like that report...tuna
China Shoe Holdings Inc. Launches Online Store
Wednesday June 11, 9:30 am ET
SHANGHAI, China, June 11 /Xinhua-PRNewswire-FirstCall/ -- China Shoe Holdings (OTC Bulletin Board: CHSH - News) announced today the launch of their online store, http://www.a139139.com, as another important milestone in the Company's retail strategy. China Shoe spent extensive efforts to research and implement the online store. It is designed with the aim of achieving the maximum usability and user-friendliness for target customers.
ADVERTISEMENT
Customers can browse through China Shoe's latest offerings and will also be able to make their purchases electronically. While the Company continues to expand its bricks and mortar retail network stores, the online store will provide customers with another channel of purchase. Moreover, it will also present the Company an additional avenue to market its brands of Kanggies and CCR in the cyberspace. Special features such as promotional discounts, tailor-made services and exclusive online items are available to ensure the greatest synergy with the chain stores.
Mr. Gu Xianzhong, Chairman and CEO of China Shoe Holdings, indicated that the online store and the retail chain are complimentary and synergistic to each other. The goal of the online store would be to achieve a significant portion of the Company's revenue within two years.
About China Shoe Holdings, Inc.
Based in Shanghai, China, China Shoe Holdings manufactures, designs and sells private labels and its own branded footwear throughout China and in overseas markets, principally Japan. China Shoe Holdings has its own manufacturing facilities located in China. China Shoe Holdings has built a diversified customer base throughout China and overseas.
Once CJGH puts out their Q1, they will not be taking to lightly....grossly undervalued!
Roger that 2MGs ....Sky One Medical Inc.... on the AMEX
the numbers :
http://finance.yahoo.com/q/ks?s=CSY
Full Time Employees: 1,443
BUSINESS SUMMARY
China Sky One Medical, Inc., through its subsidiaries, engages in the development, manufacture, marketing, and sale of over-the-counter nutritional supplements and herb based pharmaceutical and medicinal products primarily in the People's Republic of China. It offers cosmetics, medical devices, and external use medicinal or pharmaceutical external use products in various forms, including sprays, ointments and creams, powders, and patches. The company's products include sumei slim patch to foster weight loss and prevent weight gain; pain killer patch used for the treatment of various ailments, including fever, headache, dysentery, diarrhea, and stiffness and pain in the neck caused by hypertension; anti-hypertension patch that improves circulation and reduces blood pressure; dysmenorrheal patch for pain relief from dysmenorrheal in a woman's critical days, and for regulating pain and catamenia; yin ke psoriasis spray; wart removing spray; chilblain ointment; hemorrhoids ointment for sterilizing and relieving hemorrhoid symptoms, including itching, distending pain, burning, and bleeding; tinea pedis spray, ointment and powder for killing various pathogens on the skin surface and subcutaneously, such as mycete, trichopytic, staphylococcal bacteria aureus, bacillus coli, and candida albicans; dermatitis spray; dandruff treatment herbal shampoo; and runze eye drop. It also offers cardiac arrest early examination kit and kidney disease testing kit, as well as various products made from Chinese herbs and plants, including a leukoderma ointment, rheumatism spray, Coryza powder, Hircus removing spray, gonorrheal cleaning spray, a snoring retardant, deodorants, diet tea, cough arresting patch, and pharyngitis spray. In addition, the company engages in the sale of medicinal and pharmaceutical products manufactured by others. It sells products through pharmaceutical chains. The company was founded in 1994 and is headquartered in Harbin, the People's Republic of China.
Ibox Updated Friend(s)
Good Day and Good Luck,
JT
CHSH has been added to the StockCharts list.
I also don't know if people have seen this from the CHSH website:
"The total current production of China Shoe Holdings, Inc. is sold up to December 2008."
http://chinashoeholdings.com/sale.htm
Not sure what to make of that as I don't know what their production capacity is...but it sounds good, lol.
CHSH board here if any interested. Still quiet there- not much hype/bs.
http://investorshub.advfn.com/boards/board.aspx?board_id=9995
They also launched online sales of the "Kanggies" brand
http://www.Kanggies.com
http://www.Kanggies.net
They didn't mention that in the pr though...not sure why they didn't.
This company is already profitable (compared to CROX, which lost .05/share last Q), and should grow fast now that they're getting into high margin retail shoes.
I know this will sound like pumping...but I'm going to say it anyway...I think this one could be over $1/share by eoy if this brand takes hold in China and Japan.
China Shoe Holdings Holds Successful Media Event in Shanghai, China
First of many retail stores open.
Press Release Source: China Shoe Holdings, Inc.
China Shoe Holdings Holds Successful Media Event in Shanghai, China
Wednesday June 4, 9:14 am ET
SHANGHAI, China, June 4 /Xinhua-PRNewswire-FirstCall/ -- On May 28, 2008, China Shoe Holdings (OTC Bulletin Board: CHSH - News) held a media event to promote its own brands, Kanggies and CCR, to the public in Shanghai. More than twenty reporters from various TV stations, newspapers and trade publications, as well as representatives from dozens of department stores and shopping malls attended the event.
ADVERTISEMENT
Kanggies brand positions in the medium to high-priced market segment with white-collar working women being the main target consumers. CCR brand's focus is on economically-priced shoes targeting the mass public, especially consumers residing in city suburbs or less developed counties. China Shoe will promote both brands through its self-owned retail stores as well as other franchised outlets. Two Kanggies stores have already been opened and ten more are expected to commence by July of 2008. A plan to open up 30 CCR stores is under consideration and it will move forward in mid June.
Mr. Gu Xianzhong, President and CEO of China Shoe Holdings, indicated that this media event demonstrates how the company is rapidly executing its retail strategy. Having conducting vigorous research during the past six months, the management is optimistic about the PRC's footwear retail market and the company's ability to become a major player in it.
About China Shoe Holdings, Inc.
Based in Shanghai, China, China Shoe Holdings manufactures, designs and sells private label and its own branded footwear throughout China and in overseas markets, principally Japan. China Shoe Holdings has its own manufacturing facilities located in China. China Shoe Holdings has built a diversified customer base throughout China and overseas.
Safe Harbor Statement
This release may contain forward-looking statements. These forward-looking statements are neither promises nor guarantees, but involve risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements. Readers should not place undue reliance on any such forward-looking statements that are based solely on information known as of the date of this release. China Shoe Holdings, Inc. disclaims any obligation to update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based or that may affect the likelihood that actual results will differ from those contained in the forward-looking statement.
--------------------------------------------------------------------------------
Source: China Shoe Holdings, Inc.
http://biz.yahoo.com/prnews/080604/cnw023.html?.v=22
KWBT - this will be the year of KWBT. Lot of exciting news to come this summer....
See the charts below....
and visit iboard to learn more
* UTVG Charts * 2.22 X 2.27 NICE CALL FRIEND.... Up over 5%
nice cup n handle formed on the 6 Month daily ...also looks good on the 1 Yr week...., ....now I hope the other indicators turn for you as well... Good Luck and Good Day,
JT
2 YR Daily
UTVG,,,,should have a bad day today but look for a come back very soon.----Do a little DD and see Y----not in but will be fishing the bottom for this one.
KWBT NEWS OUT !!! Two years of waiting and the result is here!
http://biz.yahoo.com/e/080527/kwbt.ob8-k.html
* KWBT Charts * .062
( 1 month daily, 3 month daily, 1 year weekly)
(3 month daily)
(6 Month Daily w/ ADX,..................................... 6 Month w/ Psar & PPO)
( 1 yr daily , .................................................... 1 yr daily )
1 YR Weekly ,........2 YR Daily
KWBT - HUGE POTENTIAL!!!!
Shandong manufactory bio-fertilizer capacity:
After 1st stage of upgrade: 11,200 tons (finished)
2nd stage of upgrade (expect to finish 2nd quarter): 18,700 tons plus 30,000 tons Bio-compound fertilizers & 300 tons Bacillus spp. powder."
One (1) ton of biofertilizer they sell for cca 1,100 USD
till now they were selling cca one hundered (100) tons per quater, annualy it makes cca 4,400,000 USD only for biofertlizers with gross profit around over 30%.
If they fulfill the capacity of 11,200 tons (actual capacity) then we have the revenues from bio fertilizers 12,320,000 USD. Gross profit 30% would mean then cc 3,700,000 annualy.
And if you see, the operating expenses per first quater were 550,000 usd what makes 2,200,000 annualy!!!
Even if operating expenses will come higher it should never grow as extremely as revenues.
But I understand from above they want to increase they production capacity to over 48,000 tons!!! And even this year, or better say this quater!!! Why such investment in facilities, if 11,200 tons capacity is not oversold yet???!!!
If this factory will run only on 50% of capacity in 2009,then the revenues from sales of bio fertilizers only will reach 26,400,000 usd, that makes gross profit 7,900,000, If operating expenses will reach even 4,000,000 usd, then we have here still EPS at cca 0,045 per share. OTC shares are usually with their PPS 10-15x higher then EPS, so value of 0.50 usd PPS is just behind the corner.
Please note, that this has been calculated for only biofertilizers, with gross profit margin only 30%, and with capacity only 50%!!!!!!!!!!
There is also bio feed, there is AF-10 factory to be launched and some other projects...
GO KIWA!!!! With growig life standard in China, India etc. the demand not only for oil but also for food is dramaticaly increasing. So do the price of course. The lands will stay the same so only chance for higher production of food are fertilizers. And at these days more and more just bio fertilizers. We maybe would be able to live without oil one day, maybe....but we will be never able to go on without food. We are in future hottest sector now I believe.....
Chased SGZH this morning. Bought CSOL (China Solar Clean Energy) instead.
I like CSOL here. Revenues and income up big-time, but EPS down .01/share due to dilution. But the dilution was for two acquisitions that will begin adding to revenues/income in Q2. Stock down after Q1 reported, but if you can hold it for another Q or two, it should be fine.
Still looking to buy more CHSH.OB on a pullback, and will watch SGZH.
GL
Thanks JT.
CHSH might pull back a bit, where I'm planning to buy more. I emailed their pipe investor (Magellan Global Fund) two weeks ago asking if their Q would be on time, and if the company now had the funding (from Magellan)to begin launch the retail end of the business. This was their reply:
"Yes, we believe that they have sufficient funds to begin their retail expansion in China, from what we understand they should be on time with their Q. We are not aware of what will be in their press release.
Our involvement with China Shoes is long term and we will continue to fund them in order for them to successfully execute their business plan.
Best regards,"
Well, CHSH reported on time as the email said they would...so I believe they're being honest (hard to believe in a penny stock, I know) that the company has the cash in hand to launch their "Kangies" brand now.
"Kangies", the Crocs of China. I still like that! Once people find out about this one, it could turn out to be red hot.
NICE Call Friend ....more gain to come too, imo ....
....also, the charts in the ibox are courtesy of stockcharts.com not profitspi.com but I do use profitspi when stockcharts's charts aren't working .....they always work.....smallcapcenter charts are excellent too, my compliments....
{your chart posted here}
.....also Friend.... I found the link to make requests ....please keep this message and spread the word on adding some more of these great chinese undervalued $tock$ ....
Good Luck and TTYS Friend....
JT
http://stockcharts.com/help/doku.php?id=support:feedback:symbol_request
Took a look at SGZH and I like it- will probably try to get some next week.
The growth in some of these China microcaps over the last year or so is amazing, and if you buy and hold a few of them for 6-12 months, you can do quite well.
SGZH...Strong EPS numbers are hidden in this Chinese coal company's 10Q released 5/13/08. Pro-forma results, which includes two acquisitions that closed on 4/4/08, show Q1 EPS of $0.55. Songzai did not release these numbers in their Q1 earnings PR, so the only way to see them is in the 10Q (page 9)...
http://sec.gov/Archives/edgar/data/1145761/000121465908001084/f5128410q.htm
Here's the earnings PR which shows $0.22 eps but does not include the acquisitions...
http://biz.yahoo.com/iw/080513/0396721.html
Very low A/R with strong cash & equiv.
Forward PE (based on pro-forma EPS) = 3.93.
Did a reverse split a few months ago so they may be looking to uplist. Not sure though.
Currently trading in the $8's, up from $7 on Tues. Not sure how many stock holders are even aware of the pro-forma numbers, but I'm going to guess not many. The Q2 earnings report could be a huge surprise (due out in Aug) especially if coal prices remain high.
May be a good one for the watch list.
Coal chart...
http://futuresource.quote.com/charts/charts.jsp?s=FT2Q%208N-EEX
hmm..I guess it's not in the profitspi.com database.
I like this chart style better personally.
http://www.smallcapcenter.com/charts/newchart.asp?ticker=chsh&P1=chsh&P8=1&P17=1&P35=66cc66&P36=ff3300
Anyway, CHSH up 44% yesterday (volume light though) in response to their Q1 earnings...which was almost as much as they made in all of 2007.
Now...once the company starts opening up their "Kangies" brand retail stores and then franchising them in July (they have the funding for it), I can see the stock easily hitting the highs of last year (.80+)or more.
NP...yes we were all over those!! thx
Looking Great Max22.....
Thanks alot for coming by the Board.....Nice link....will add to the IBOX....sooon with some other links as well....China has been red hot .
...hope you had some of that KUN, RCH, or JRJC....check out the vast selection in the Ibox if you please.
or the Possibilities Board.... http://investorshub.advfn.com/boards/board.asp?board_id=9282
Cheers Friend and Thanks again
Blue Skies, Green Screens,
JT
(had you personmarked)
Followers
|
39
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
407
|
Created
|
07/21/07
|
Type
|
Free
|
Moderators |
This board is only to be used to discuss Chinese stocks publicly traded in the American market or stocks that have a significant business in China. So far we have listed a few on this board which we believe has the best chance of making money.
Here are some top choices below
ACTS(Actions Semiconductor Co) Nasdaq listed
****On watch w/ a buy rating****
Actions Semiconductor is one of China's leading fabless semiconductor companies that provides mixed-signal and multimedia SoC solutions for portable consumer electronics. Actions Semiconductor products include SoCs, firmware, software, solution development kits, as well as detailed specifications of other required components and the providers of those components. Actions Semiconductor also provides total product and technology solutions that allow customers to quickly introduce new portable consumer electronics to the mass market in a cost effective way. The company is headquartered in Zhuhai, China, with offices in Beijing and Shenzhen. For more information, please visit the Actions Semiconductor website at http://www.actions-semi.com.
ACTS is at the lowest in it's 1 year chart. Not a bad pick considering the following:
Revenues around $100M+ for 2007 with expanding revenues year after year
86 M shares outstanding
$200M+ in cash assests
Investor Relations Contacts
Actions Semiconductor Investor Relations
15-1, NO.1, HIT Road, Tangjia, Zhuhai, Guangdong, 519085
China
Phone: +86 756 3398 229
E-mail:investor.relations@actions-semi.com
The Blueshirt Group Investor Relations for Actions Semiconductor
Suzanne Craig or Lisa Laukkanen
456 Montgomery Street, 11th Floor
San Francisco, CA 94104
USA
Phone: +1 415 217 7722
Fax: +1 415 217 7721
CSUN (China Sunergy Co Ltd) Nasdaq Listed
***Buy***
About China Sunergy
We are a leading manufacturer of solar cell products in China as measured by production capacity and a pure-play cell manufacturer focusing on the highest value segment of the solar value chain. We manufacture solar cells from silicon wafers utilizing crystalline silicon solar cell technology to convert sunlight directly into electricity through a process known as the photovoltaic effect. We sell solar cell products to Chinese and overseas module manufacturers and system integrators, who assemble our solar cells into solar modules and solar power systems for use in various markets.
***10MW sales contract with Solarwatt AG, a leading solar module manufacturing company in Germany, for the second half of 2007 with a total contract value of approximately EUR21.7 million, along with other European sales expansion and the recently announced approval of their N-Type Cell Patent, which is covered for 20 years, should keep China Sunergy a major player in the solar industry in China. If you have seen what JASO and TSL have done since their IPO, I believe the same is in line for China Sunergy.
Company website: http://www.chinasunergy.com/en/index.php
Investor Relations Contacts
Primary IR Contact
Fischer Chen
VP of Finance and Investor Relations
Phone: 86-25-52766688
Fax: 86-25-52766882
E-mail: fischer.chen@chinasunergy.com
Peter Schmidt
FD US
Phone: + 1 (212) 850-5654
E-mail: peter.schmidt@fd.com
Julian Wilson
Senior Vice President
FD Asia
Phone: 86-10-58111902
E-mail: julian.wilson@fd.com
Board info: http://investorshub.advfn.com/boards/board.asp?board_id=9482
Other Chinese stocks to watch for:
CHNG (China Natural Gas)OTC BB
China Natural Gas, Inc. is a US Delaware registered public company that owns and operates its natural gas related businesses in China. China Natural Gas is the first China based natural gas company publicly traded in the US capital markets (stock symbol: CHNG). Managed by seasoned industry executives, the Company owns a 120 kilometer long Compressed Natural Gas (CNG) pipeline located in the city of Xi'An (Population 8.5 million), the capital city of China's Shaanxi Province and a gateway to China's vast western regions. The northern region of Shaanxi Province is the home to China's second largest natural gas reserve. The Company has been consistently profitable since its inception.
China Natural Gas is the sole authorized provider of natural gas to residential customers in certain parts of the Xi'An area, including Lantian County and the Baqiao District. The Company is rapidly expanding its network of compressed natural gas filling stations to satisfy strong customer demand.
In August 2006, the Company announced expansion of their retail natural gas business into China's Henan Province, which is China's most populous province with a population of 100 million.
Board info: http://investorshub.advfn.com/boards/board.asp?board_id=5422
Company website: www.naturalgaschina.com
Investor Relations
Ashley Ammon MacFarlane
Bill Zima
Integrated Corporate Relations
1-203-682-8200
XSNX (XSunX Inc) OTC BB
Based in Aliso Viejo, Calif., XsunX is developing and commercializing innovative new thin film photovoltaic (TFPV) solar cell technologies and manufacturing processes to service expanding global energy demands. The Company has focused its efforts on lowering the cost per watt of solar power and making solar cell technology easier to use in a wide variety of applications.
Company website: http://www.xsunx.com/
Investor Relations at XsunX, Inc.
1-888-797-4527
Board info: http://investorshub.advfn.com/boards/board.asp?board_id=3771
CLCL(CalCol Inc)
100% China subsidiary Malibu-Cola Beverage Co. Ltd. of Beijing has sales contracts now binding and in effect for nationwide rollout to all Wal-Mart, Sam's Club, Tesco, and Carrefour stores throughout China to begin December 2005. CALCOL currently manufactures and distributes in China, primarily in Chinese supermarkets and through local distributors in the 10 major cities in Hebei province and Beijing and Tianjin, Malibu-Cola, Malibu Sunrise Orange, Malibu Surf's Up Lemon Lime, Malibu Verry Cherry Cola, and Malibu Lemon Squeeze Carbonated Lemonade, as well as Malibu Diet Dee-Lite Cola in 500 ml, 1.25 liter, 2 liter pet bottles, and 355 ml aluminum cans. The products retail at a discount of 20%-25% below the retail price of other American colas sold in China.
Company website: http://www.calcol.com/
Contacts
CALCOL INC.
Norman C. Kaplan, (86-10) 6159-4104
US tel: 216-514-0849
Fax: (86-10) 6159-2166
US fax: 216-274-9608
Email: calcol@aol.com
IFSG (Infosmart Group Inc)OTC BB
Infosmart operates state of the art DVDR production facilities in Hong Kong and Brazil and is preparing to manufacture new writable High Density media (HD-DVDR). In addition, the Company expects to become one of the largest manufacturers of DVDR discs in Brazil and all of South America this year. Disc media will be the storage media of choice for years to come, whether as HD-DVDR for mature markets or traditional DVDR for developing markets. No other storage media available rivals its combination of high capacity, low cost and exceptional portability.
Company website: http://www.infosmart.com.hk/
Investor Relations
Justin K. Davis
jd@keatingams.com
Phone: (720) 489-4913
Fax: (303) 728-3542
***Company just announced record revenue and production and looks to expand in Brazil. Looks good for the future at the current price.
Others to watch out for:
CBAK(China BAK Battery Inc)Nasdaq listed
CAAS(China Automotive Systems Inc)Nasdaq listed
CCGY(China Clean Energy Inc)OTC BB
CCBX(China Career Builder Corp)OTC
CDGT(China Digital Media Corp)OTC BB
CHID(China Digital Communication Group)OTC BB
GRRF(China Grentech Corp Ltd)Nasdaq listed
CNOA(China Organic Agriculture Inc)OTC BB
AND SOME BENEFICIAL LINKS:
http://chinabizfocus.com/modules/InvestChina/performances.php?sel=performances&perf=ytd
THREE CHINESE ETF's
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |